Platform
Features
Pricing
Turnstone Biologics
Contact
Tj Langer is the SVP, Cell Therapy Development & External Innovation at Turnstone Biologics. Previously, he was the CEO (Acquired By Turnstone) at Myst Therapeutics.
Links
Previous companies
Tj Langer
SVP, Cell Therapy Development & External Innovation
Sign up to view 0 direct reports
Get started
This person is not in any teams
Entos Pharmaceuticals
Inari
Kriya Therapeutics
BeiGene
Valo